Yes, they're on to something, and I hope "large pharma" gets interested, because Oncolytics is one of many companies seeking to fight cancer by revolutionary medicine.
"Expanding clinical collaborations with large pharma in an effort to support further development around the innate and adaptive immunity components of REOLYSIN's MOA."(Today's PR)